22nd Century Group, Inc.
(NYSE Amex Equities : XXII)

( )
XXII PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
REGNRegeneron Pharmaceuticals, Inc. -0.73%572.402.7%$664.87m
AMGNAmgen, Inc. -0.92%228.971.3%$587.18m
ILMNIllumina, Inc. -0.81%317.853.5%$555.47m
GILDGilead Sciences, Inc. -0.56%60.211.0%$501.35m
VRTXVertex Pharmaceuticals, Inc. -1.47%211.381.9%$488.35m
ARRYArray BioPharma Inc. 2.18%39.3414.2%$478.36m
MRNAModerna, Inc. -4.12%68.370.0%$471.73m
IMMUImmunomedics, Inc. 0.11%87.8211.0%$373.27m
NVAXNovavax, Inc. -7.32%91.1696.5%$302.79m
ALXNAlexion Pharmaceuticals, Inc. -4.69%118.192.0%$280.41m
BIIBBiogen, Inc. 0.67%268.911.6%$264.60m
EXASEXACT Sciences Corp. -3.31%99.6120.7%$219.55m
BNTXBioNTech SE -7.03%87.720.0%$214.67m
SRNESorrento Therapeutics, Inc. -4.50%7.851.4%$181.33m
SGENSeagen Inc. -0.16%197.716.0%$162.37m

Company Profile

22nd Century Group, Inc. is a plant biotechnology company, which engages in the development of technology that will allow increasing or decreasing the level of nicotine and nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. Its products include X-22, modified risk cigarettes, spectrum government research cigarettes, magic 0 and magic 2, moonlight, red sun, variable nicotine-level research cigarettes, and verfola. The company was founded on September 12, 2005 and is headquartered in Clarence, NY.